NEW YORK (GenomeWeb) – HTG Molecular Diagnostics reported on Thursday a 200 percent surge in first quarter revenues driven by its collaborative development services activities with pharma partners.
For the three-month period ended March 31, HTG's revenues climbed to $4.2 million from $1.4 million in the same period the year before.